Search
for
Sort by
Research 61–90 of 1000+
- Lineage Commitment of Dermal Fibroblast Progenitors is Mediated by Chromatin De-repression
- Introduction to Transplantology
- Bioengineering Skin Constructs
- Ritlecitinib (Litfulo)
- Cost‐Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Patient satisfaction with hair regrowth in a study of ritlecitinib: a plain language summary
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- Whole-Cell Bioprocessing of Human Fetal Cells for Tissue Engineering of Skin
- Human FOXN1-Deficiency Is Associated with αβ Double-Negative and FoxP3+ T-Cell Expansions That Are Distinctly Modulated upon Thymic Transplantation
- Advances in scalp reconstruction
- Dermatological Complications in Transplant Patients and Composite Tissue Allotransplant Pathology
- The Effect of Drugs on Hair
- Allogeneic Hair Transplantation with Enhanced Survival by Anti-ICAM-1 Antibody with Short-Term Rapamycin Treatment in Nonhuman Primates
- Application of second near infrared fluorescence imaging to trace CelTrac1000-labeled hair follicle epidermal neural crest stem cells in repairing rat facial nerve defects
- The comparison of the mesenchymal progenitor cell coating state on the MBA and DBM as the biochemical scaffolds
- Lineage commitment of dermal fibroblast progenitors is controlled by Kdm6b‐mediated chromatin demethylation
- Management of Avulsive Soft Tissue Ballistic Facial Injuries
- Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair
- INNOVATIVE THERAPIES IN REGENERATIVE MEDICINE AND TRANSPLANTATION
- Hypertrichosis of the eyelashes caused by bimatoprost
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- Ritlecitinib in severe alopecia areata: a profile of its use
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos